Busan, South Korea

Eun Young Park

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Eyebio Korea. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eun Young Park. Retrieved from https://idiyas.com/inventor/eun-young-park-7f9rwqcy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eun Young Park: Innovator in Peptide Compounds

Introduction

Eun Young Park is a prominent inventor based in Busan, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on peptide compounds. Her dedication to research and development has led to the creation of valuable intellectual property.

Latest Patents

Eun Young Park holds 1 patent for a novel peptide compound or a pharmaceutically acceptable salt thereof. This invention relates to a unique peptide compound that has potential applications in the pharmaceutical industry, showcasing her expertise and innovative spirit.

Career Highlights

Eun Young Park is currently associated with Eyebio Korea, where she continues to advance her research in peptide compounds. Her work at the company reflects her commitment to improving healthcare through innovative solutions.

Collaborations

Eun Young Park collaborates with talented individuals such as Yoo Seok Kim and Myoung Hwan Kim. These partnerships enhance her research efforts and contribute to the development of groundbreaking pharmaceutical solutions.

Conclusion

Eun Young Park is a remarkable inventor whose work in peptide compounds has the potential to impact the pharmaceutical industry significantly. Her contributions and collaborations highlight her role as a leader in innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…